UROLOGY SALVAGE OF SILDENAFIL FAILURES FROM PRIMARY CARE PHYSICIANS

VARDENAFIL IMPROVES ERECTILE FUNCTION REGARDLESS OF ETIOLOGY OR BASELINE SEVERITY IN MEN WITH ERECTILE DYSFUNCTION

ORLANDO - May 25, 2002 -Vardenafil significantly improved erectile function (EF) in men suffering from erectile dysfunction (ED), regardless of the origin or baseline severity of their condition, according to a new study conducted by Craig Donatucci, M.D., urologist in practice at the Duke University Medical Center in Durham, NC. His findings will be presented at the American Urological Association Annual Scientific Meeting on May 27 at 2:20 p.m. during a podium session.

STUDY SHOWS NEW INVESTIGATIONAL DRUG TADALAFIL SUCCESFULLY TREATED ERECTILE DYSFUNCTION UP TO 36 HOURS AFTER DOSING

ORLANDO - May 25, 2002 - Erectile dysfunction is a strong indicator of future forms of ischemic heart disease, according to a study conducted by Dr. Francesco Montorsi at the University Vita - Salute, Scientific Institute H. San Raffaele in Milan. He will present his findings at the American Urological Association's Annual Scientific Meeting during a poster session on May 27, 2002, starting at 10:00 a.m.

ORLANDO - May 25, 2002 - A single injection of naked human maxi-K gene into penile smooth muscle chronically reversed the effects of aging for up to six months in a rat model and may be successful in the long-term treatment of age-related erectile dysfunction, according to new research from the Albert Einstein College of Medicine in New York. Arnold Melman, M.D. will present the study during an unmoderated poster session on Tuesday, May 28.